Dehydration on a GLP-1 Is a Real Risk Heres How to Make Sure Youre Drinking Enough If youre on a GLP-1 medication for obesity or diabetes, you may experience common side effects like nausea, vomiting, diarrhea, or constipation
Squalane, being similar to the skins natural sebum components, masterfully restores the lipid layer, while eggplant extract provides an additional calming effect, making the cream suitable even for the most sensitive skin
Thats why Defy Medical offers science-backed, provider-guided Weight Management plans to help you reach your fitness and weight loss goals

In a post on X, Hims & Hers' chief executive, Andrew Dudum, said that the company will "continue to offer access to personalised treatments as allowed by law to meet patient needs," and will be "closely monitoring" the semaglutide supply chain, given that Novo Nordisk "stated two weeks ago that it would continue to have 'capacity limitations' and 'expected continued periodic supply constraints and related drug shortage notifications'." For its part, the FDA said it "has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved." The agency will continue to allow compounders to provide semaglutide to patients on a temporary basis "to avoid unnecessary disruption to patient treatment." State-licensed pharmacy or physician compounders can continue to do so until 22nd April, while outsourcing facilities have a deadline of 22nd May